In this study,we investigate two different cell models of ACC, namely, SW13 and H295R lines, whetherthe TZD RGZ may exert its antiproliferative action on human ACC cell lines byinterfering with the intracellular pathways activated by IGF-IR. The gene discussed is IGF1R; the disease is adrenal cortex carcinoma.